F Dx Advisors, Inc. Novartis Ag Transaction History

F Dx Advisors, Inc.

$659 Million
Q1 2024

A detailed history of F Dx Advisors, Inc. transactions in Novartis Ag stock. As of the latest transaction made, F Dx Advisors, Inc. holds 4,694 shares of NVS stock, worth $501,225. This represents 0.07% of its overall portfolio holdings.

Number of Shares

4,694

Previous 16,369 71.32%

Holding current value

$501,225

Previous $1.65 Million 72.53%

% of portfolio

0.07%

Previous 0.13%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$95.27 - $108.47 $1.11 Million - $1.27 Million	-11,675 Reduced 71.32%	4,694 $454,000
Q4 2023 Feb 12, 2024	BUY	$92.27 - $101.54 $60,067 - $66,102	651 Added 4.14%	16,369 $1.65 Million
Q3 2023 Nov 02, 2023	SELL	$94.73 - $105.13 $1.32 Million - $1.47 Million	-13,946 Reduced 47.01%	15,718 $1.6 Million
Q2 2023 Jul 17, 2023	SELL	$92.52 - $104.91 $2.6 Million - $2.95 Million	-28,123 Reduced 48.67%	29,664 $2.99 Million
Q4 2022 Feb 09, 2023	SELL	$75.55 - $92.52 $70,714 - $86,598	-936 Reduced 1.59%	57,787 $5.24 Million

Q3 2022 Nov 10, 2022	SELL	$74.61 - $87.26 $438,557 - $512,914	-5,878 Reduced 9.1%	58,723 $4.46 Million
Q2 2022 Aug 03, 2022	BUY	$80.52 - $93.75 $143,647 - $167,250	1,784 Added 2.84%	64,601 $5.46 Million
Q1 2022 May 03, 2022	BUY	$80.11 - $90.62 $308,183 - $348,615	3,847 Added 6.52%	62,817 $5.51 Million
Q4 2021 Feb 01, 2022	BUY	$79.7 - $88.13 $921,810 - $1.02 Million	11,566 Added 24.4%	58,970 $5.16 Million
Q3 2021 Oct 08, 2021	BUY	$81.78 - $95.14 $284,676 - $331,182	3,481 Added 7.93%	47,404 $3.88 Million
Q2 2021 Aug 05, 2021	BUY	$85.24 - $94.15 $130,331 - $143,955	1,529 Added 3.61%	43,923 $4.01 Million
Q1 2021 Apr 14, 2021	BUY	$83.5 - $98.47 $3.24 Million - $3.82 Million	38,770 Added 1069.81%	42,394 $3.62 Million
Q1 2021 Apr 13, 2021	SELL	$83.5 - $98.47 $3.64 Million - $4.29 Million	-43,601 Reduced 92.33%	3,624 $309,000
Q4 2020 Feb 08, 2021	BUY	$78.07 - $94.43 $359,824 - $435,227	4,609 Added 10.82%	47,225 $4.46 Million
Q3 2020 Nov 12, 2020	BUY	$82.14 - $91.0 $58,976 - $65,338	718 Added 1.71%	42,616 $3.71 Million
Q2 2020 Jul 22, 2020	BUY	$80.93 - $91.1 $234,292 - $263,734	2,895 Added 7.42%	41,898 $3.66 Million
Q1 2020 May 22, 2020	BUY	$70.67 - $99.01 $481,404 - $674,456	6,812 Added 21.16%	39,003 $3.22 Million
Q1 2020 May 13, 2020	SELL	$70.67 - $99.01 $118,230 - $165,643	-1,673 Reduced 4.94%	32,191 $53,000
Q4 2019 Feb 12, 2020	BUY	$84.35 - $95.37 $434,486 - $491,250	5,151 Added 17.94%	33,864 $3.21 Million
Q3 2019 Nov 07, 2019	SELL	$85.54 - $94.26 $1.84 Million - $2.03 Million	-21,544 Reduced 42.87%	28,713 $2.5 Million
Q2 2019 Jul 19, 2019	BUY	$75.4 - $92.8 $692,926 - $852,832	9,190 Added 22.38%	50,257 $4.59 Million
Q1 2019 May 14, 2019	BUY	$75.32 - $86.15 $1.18 Million - $1.34 Million	15,604 Added 61.28%	41,067 $3.95 Million
Q4 2018 Apr 29, 2019	SELL	$73.66 - $82.02 $2.22 Million - $2.47 Million	-30,146 Reduced 54.21%	25,463 $2.19 Million
Q4 2018 Feb 07, 2019	BUY	$73.66 - $82.02 $686,953 - $764,918	9,326 Added 20.15%	55,609 $4.77 Million
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $58,773 - $67,983	878 Added 1.93%	46,283 $3.99 Million
Q2 2018 Aug 08, 2018	SELL	$64.91 - $73.36 $168,766 - $190,736	-2,600 Reduced 5.42%	45,405 $3.43 Million
Q1 2018 May 02, 2018	BUY	$70.39 - $84.15 $189,912 - $227,036	2,698 Added 5.95%	48,005 $3.88 Million
Q4 2017 Feb 09, 2018	BUY	$72.33 - $77.64 $508,841 - $546,197	7,035 Added 18.38%	45,307 $3.8 Million
Q3 2017 Nov 03, 2017	BUY	$74.14 - $77.27 $410,439 - $427,766	5,536 Added 16.91%	38,272 $3.29 Million
Q2 2017 Aug 11, 2017	BUY	N/A	32,736	32,736 $2.73 Million

Others Institutions Holding NVS

# of Institutions

1,349

Shares Held

140M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $230B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.

Account